0001171843-16-010709.txt : 20160616
0001171843-16-010709.hdr.sgml : 20160616
20160616163102
ACCESSION NUMBER: 0001171843-16-010709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160616
DATE AS OF CHANGE: 20160616
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001365216
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133929237
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 KING FARM BOULEVARD, SUITE 550
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 3019613400
MAIL ADDRESS:
STREET 1: 805 KING FARM BOULEVARD, SUITE 550
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenleaf Peter
CENTRAL INDEX KEY: 0001363683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33609
FILM NUMBER: 161717905
MAIL ADDRESS:
STREET 1: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
f4_061616greenleaf.xml
OWNERSHIP DOCUMENT
X0306
4
2016-03-31
0
0001365216
Sucampo Pharmaceuticals, Inc.
SCMP
0001363683
Greenleaf Peter
805 KING FARM BLVD, SUITE 550
ROCKVILLE
MD
20850
0
1
0
0
Chief Executive Officer
Common Stock, Class A (ESPP)
2016-03-31
5
A
0
E
646
9.29
A
1122
D
The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period January 1, 2016 through March 31, 2016. This transaction is exempt under Rule 16(b)-3(c).
In accordance with the ESPP, these shares were purchased at 85% of the closing price of the issuer's common stock on March 31, 2016.
/s/ Peter Greenleaf
2016-06-16